Comparing GnRH agonist long protocol and gnrh antagonist protocol in outcome the first cycle of ART

Archives of Gynecology and Obstetrics

Volumn 281, Issue 1, 2010, Pages 81-85

  Firouzabadi, Razieh Dehghani ^a   Ahmadi, Shahnaz ^a   Oskouian, Homa ^a   Davar, Robab ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Assisted reproductive technology; GnRH agonist; GnRH antagonist; Ovarian stimulation; Pregnancy rate

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; ASSISTED REPRODUCTIVE TECHNIQUE; BODY MASS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PREGNANCY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; BUSERELIN; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES;

EID: 71449083521     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1073-5     Document Type: Article

References (28)

1. RG Edward PC Steptoe JM Purdy 1980 Establishing full term human pregnancies using cleaving embryos grown in vitro Br J Obstet Gynaecol 87 737 756
2. CM Howel MC Macnamee RG Edwards, et al. 1986 Effects of high tonic levels of luteinizing hormone on outcome of IVF Lancet 2 521
3. R Fleming JR Couttes 1986 Introduction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression Fertil Steril 45 3 226
4. F Olivennes JS Cunha-Filho R Fanchin, et al. 2002 The use of GnRH antagonist in ovarian stimulation Hum Reprod Update 8 279 290 10.1093/humupd/8.3.279 1:CAS:528:DC%2BD38Xlt1Ckt7w%3D 12078838 (Pubitemid 34618945)
5. H AI-Inany M Aboulghar 2002 GnRH antagonist in assisted conception: a Cochrane Review Hum Reprod 17 874 885 10.1093/humrep/17.4.874
6. O Marologlu S Kilic R Karalycin, et al. 2008 Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients Adv Ther 25 3 266 267 10.1007/s12325-008-0028-8
7. RE Felberbaun C Albano M Ludwig, et al. 2000 European Cetrorelix Study Group Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study Hum Reprod 15 1015 1020 10.1093/humrep/15.5.1015
8. The European and Middle East Orgalutran Study Group 2001 Comparable clinical outcomes using the GnRH agonist Triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum Reprod 16 644 651 10.1093/humrep/16.4.644
9. The North American Ganirelix study Group 2001 Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation Fertil Steril 75 38 45 10.1016/S0015-0282(00)01638-1 (Pubitemid 32041225)
10. M Ludwig RE Felberbaum P Devroey, et al. 2000 Significant reduction of the incidence of ovarian hyperstimulation syndrome by using the LHRH antagonist cetrorelix in controlled ovarian stimulation for assisted reproduction Arch Gynecol Obstet 264 29 32 10.1007/PL00007479 1:CAS:528:DC%2BD3cXkvFartbc%3D 10985616
11. C Albano RE Felberbaum J Smithz, et al. 2000 Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserlin Hum Reprod 15 526 531 10.1093/humrep/15.3.526 1:CAS:528:DC%2BD3cXitF2qur0%3D 10686191
12. EM Kolibianakis J Collins B Tarlatzis, et al. 2006 Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systemic review Hum Reprod Update 12 325 326 10.1093/humupd/dml005
13. C Newton D Solta AA Yuzpe IS Tummon 1996 Memory complaints associated with the use of gonadotropin- releasing hormone agonists: a preliminary study Fertil Steril 65 1253 1255 1:STN:280:DyaK283it12htw%3D%3D 8641510
14. Tarlatziz BC, Fauser BC, Kolibianakis EM et al (2006) GnRH antagonist in ovarian stimulation for IVF. Hum Reprod Update 12:333-340
15. GnRH-analog in cancer and Human Reproduction, A100. Deutsches IVF Register 2003. Annual report from the German IVF Registry 2003 ( http://www.Deutsches-ivf-register.de )
16. MA Akman HF Erden SB Tosun, et al. 2000 Addition of GnRH antagonist in cycles of poor responders undergoing IVF Hum Reprod 15 2145 2147 10.1093/humrep/15.10.2145 1:CAS:528:DC%2BD3cXnslektrs%3D 11006188
17. MA Akman HF Erden SB Tosun, et al. 2001 Comparison of agonist flare up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial Hum Reprod 16 868 870 10.1093/humrep/16.5.868 1:CAS:528:DC%2BD3MXkt1Cqsrc%3D 11331630
18. MA Aboulghar RT Mansour GI Serour, et al. 2004 Increasing the dose of human menopausal gonadotropins on the day of GnRH antagonist administration: randomized controlled trial Reprod Biomed Online 8 524 527 1:CAS:528: DC%2BD2cXksFGqtbk%3D 15151713
19. I Cedrin-Durnerin D Grange -Dujardin A Laffy, et al. 2004 Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: A prospective randomized study Hum Reprod 19 1979 1984 10.1093/humrep/deh369 1:CAS:528:DC%2BD2cXnsVyis7c%3D 15192072 (Pubitemid 39242642)
20. C Giorgetti P Terriou P Auquier, et al. 1995 Embryo score to predict implantation after in vitro fertilization based on 957 single embryo transfers Hum Reprod 10 2427 2431 1:STN:280:DyaK287itFWqtQ%3D%3D 8530679
21. E Van Royen K Mangelschots D De Neubourg, et al. 1999 Characterization of a top quality embryo, a step towards single embryo transfer Hum Reprod 14 2345 2349 10.1093/humrep/14.9.2345 10469708 (Pubitemid 29425427)
22. Practice Committee of the Society for Assisted Reproductive Technology (2006) Practice Committee of the American Society for Reproductive Medicine. Guidelines on number of embryos transferred. Fertil Steril 86(5 suppl):51-52
23. P Xavier C Camboa L Calejo, et al. 2005 A randomized s tudy of GnRH antagonist versus agonist for ovarian stimulation Eur J Obstet Gynecol Reprod Biol 120 185 189 10.1016/j.ejogrb.2004.11.005 1:CAS:528:DC%2BD2MXltVentbo%3D 15925049 (Pubitemid 40745322)
24. Tazequl A, Gorkemli H, Ozdemir S et al (2008) Comparison of multiple dose GnRH antagonist and minidose long agonist protocol in poor responders undergoing invitro fertilization: a randomized controlled trial. Arch Gynecol Obstet 278:467-472
25. Y Li Y Li O Lao, et al. 2008 Comparison between a GnRH agonist and GnRH antagonist protocol for the same patient undergoing IVF J Huazhong Univ Sci Tech Med Sci 28 618 620
26. R Orvieto J Rabinson S Meltzer, et al. 2006 GnRH agonist versus GnRH antagonist in ovarian stimulation: is the improper naker? Clin Exp Obstet Gynechol 33 197 199 1:STN:280:DC%2BD2s%2Fhs1Smuw%3D%3D
27. P Sirayapiwat S Suwajanakorn S Triratanachat, et al. 2007 The effect of GnRH antagonist on the endometrium of normally menstruating women J Assist Reprod Genet 24 579 586 10.1007/s10815-007-9184-z 18049889
28. M Fluker J Grifo A Leader 2001 Efficacy and safety of Ganirelix acetate versus leuprolide in women undergoing controlled ovarian stimulation Fertil Steril 75 38 45 10.1016/S0015-0282(00)01638-1 1:STN:280:DC%2BD3MzitF2huw%3D%3D 11163814 (Pubitemid 32041225)